Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elzbieta Slodkowska

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
The American Journal of Surgical Pathology|June 1, 2023
Mammary Spindle Cell Proliferations on Core Needle Biopsy: Is Excision Always Necessary?Cherry Pun, Gulisa Turashvili, Anna Marie Mulligan, et al.
Histopathology|January 23, 2019
PD-L1, RB1 and mismatch repair protein immunohistochemical expression in neuroendocrine carcinoma, small cell type, of the uterine cervixSarah Morgan, Elzbieta Slodkowska, Carlos Parra-Herran, et al.
Case Reports in Surgery|February 21, 2013
Epithelioid hemangioendothelioma of the mastoid: resection for recurrence and adjuvant radiation with 8-year followupDoniel Drazin, Ravi Gandhi, Elzbieta Slodkowska, et al.
Archives of Pathology & Laboratory Medicine|October 7, 2025
Clinicopathologic Features and Genomic Profile of Human Epidermal Growth Factor Receptor 2-Low and Human Epidermal Growth Factor Receptor 2-Ultralow Invasive Breast CarcinomasHarpreet Rai, Elzbieta Slodkowska, Sharon Nofech-Mozes, et al.
Histopathology|June 28, 2019
Inter- and intraobserver agreement of programmed death ligand 1 scoring in head and neck squamous cell carcinoma, urothelial carcinoma and breast carcinomaMichelle R Downes, Elzbieta Slodkowska, Nora Katabi, et al.
Pathology, Research and Practice|September 11, 2021
Development of a multiplex immuno-oncology biomarker and digital pathology workflow for assessment of urothelial carcinomaYouheng Xie, Ekaterina Olkhov-Mitsel, Samira Alminawi, et al.
International Journal of Surgical Pathology|June 12, 2023
Immunohistochemical Characterization of a Large Cohort of Triple Negative Breast CancerRachel Han, Sharon Nofech-Mozes, Dina Boles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2017
Comparative Analysis of Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer According to 2007 and 2013 American Society of Clinical Oncology/College of American Pathologists Guideline RecommendationsWedad M Hanna, Elzbieta Slodkowska, Fang-I Lu, et al.
The Breast Journal|December 3, 2020
Adequacy of invasive and in situ breast carcinoma margins in radioactive seed and wire-guided localization lumpectomiesWyanne Law, Xingshan Cao, Frances C Wright, et al.
Virchows Archiv : an International Journal of Pathology|November 11, 2020
The impact of pre-analytical parameters on class II biomarkers by immunohistochemistry: concordance across four tissue processing protocolsBin Xu, Samira Alminawi, Patrice Boulianne, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
The American Journal of Surgical Pathology|June 1, 2023
Mammary Spindle Cell Proliferations on Core Needle Biopsy: Is Excision Always Necessary?Cherry Pun, Gulisa Turashvili, Anna Marie Mulligan, et al.
Histopathology|January 23, 2019
PD-L1, RB1 and mismatch repair protein immunohistochemical expression in neuroendocrine carcinoma, small cell type, of the uterine cervixSarah Morgan, Elzbieta Slodkowska, Carlos Parra-Herran, et al.
Case Reports in Surgery|February 21, 2013
Epithelioid hemangioendothelioma of the mastoid: resection for recurrence and adjuvant radiation with 8-year followupDoniel Drazin, Ravi Gandhi, Elzbieta Slodkowska, et al.
Archives of Pathology & Laboratory Medicine|October 7, 2025
Clinicopathologic Features and Genomic Profile of Human Epidermal Growth Factor Receptor 2-Low and Human Epidermal Growth Factor Receptor 2-Ultralow Invasive Breast CarcinomasHarpreet Rai, Elzbieta Slodkowska, Sharon Nofech-Mozes, et al.
Histopathology|June 28, 2019
Inter- and intraobserver agreement of programmed death ligand 1 scoring in head and neck squamous cell carcinoma, urothelial carcinoma and breast carcinomaMichelle R Downes, Elzbieta Slodkowska, Nora Katabi, et al.
Pathology, Research and Practice|September 11, 2021
Development of a multiplex immuno-oncology biomarker and digital pathology workflow for assessment of urothelial carcinomaYouheng Xie, Ekaterina Olkhov-Mitsel, Samira Alminawi, et al.
International Journal of Surgical Pathology|June 12, 2023
Immunohistochemical Characterization of a Large Cohort of Triple Negative Breast CancerRachel Han, Sharon Nofech-Mozes, Dina Boles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2017
Comparative Analysis of Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer According to 2007 and 2013 American Society of Clinical Oncology/College of American Pathologists Guideline RecommendationsWedad M Hanna, Elzbieta Slodkowska, Fang-I Lu, et al.
The Breast Journal|December 3, 2020
Adequacy of invasive and in situ breast carcinoma margins in radioactive seed and wire-guided localization lumpectomiesWyanne Law, Xingshan Cao, Frances C Wright, et al.
Virchows Archiv : an International Journal of Pathology|November 11, 2020
The impact of pre-analytical parameters on class II biomarkers by immunohistochemistry: concordance across four tissue processing protocolsBin Xu, Samira Alminawi, Patrice Boulianne, et al.
Pageof 6